Sunshine Biopharma, Inc. (SBFM) Down 3.15% in Premarket Trading

Monday, August 08, 2022 08:14 AM | InvestorsObserver Analysts

Mentioned in this article

Sunshine Biopharma, Inc. (SBFM) is lower by Monday morning, with the stock declining -3.15% in pre-market trading to 1.23. SBFM's short-term technical score of 34 indicates that the stock has traded less bullishly over the last month than 66% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 140 out of 146 industries, SBFM ranks higher than 56% of stocks. Sunshine Biopharma, Inc. has risen 7.63% over the past month, closing at $1.15 on July 11. During this period of time, the stock fell as low as $1.03 and as high as $1.85.

SBFM has an Overall Score of 13. Find out what this means to you and get the rest of the rankings on SBFM!
Sunshine Biopharma, Inc. has a Long-Term Technical rank of 5. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 95% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 135 by this metric, SBFM ranks better than 135% of stocks.

Important Dates for Investors in SBFM:

-We do not have a set earnings date for Sunshine Biopharma, Inc. at this time. -We do not have a set dividend date for Sunshine Biopharma, Inc. at this time. Click Here To Get The Full Report on Sunshine Biopharma, Inc. (SBFM)

Share this article: